The long-term outcomes of patients with immunoglobulin G4-related sclerosing cholangitis: the Mayo Clinic experience.

Ahmad Hassan AliYan BiJorge D MachicadoSushil GargRyan J LennonLizhi ZhangNaoki TakahashiElizabeth J CareyKeith D LindorJ Gage BunessJames H TabibianSuresh T Chari

Published in: Journal of gastroenterology (2020)

In a cohort of IgG4-SC patients, 88% of whom were treated with immunosuppressive drugs, the risk of cirrhosis and CCA was significantly lower compared to an age- and gender-matched group with PSC.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
primary care
patient reported outcomes
ulcerative colitis